MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...
Heidi Crayton, MD, and Maria Lopes, MD, discuss the impact of multiple sclerosis on patients, families, and caregivers, differentiate relapsing forms (relapsing-remitting and primary progressive) from ...
Two new sub-types of multiple sclerosis (MS) were discovered by researchers from Queen Square Analytics and University ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Multiple ...
Up to 85% of the people who receive a diagnosis of the neurodegenerative disorder multiple sclerosis (MS) have the relapsing-remitting (RR) disease course. This means that people have relapses -- also ...
Exclusive: Scientists uncovered biological strands using artificial intelligence and hope discovery will revolutionise treatment ...
An experimental stem cell therapy proved effective and safe in patients with a relapsing form of multiple sclerosis (MS), an autoimmune disease that affects the central nervous system, new research ...
The team, consisting of researchers from University College London (UCL) and Queen Square Analytics, analysed 634 patients ...
Kesimpta is a medicine used to treat relapsing forms of multiple sclerosis (MS). Relapsing forms of MS include clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS ...
Scientists from UCL have used artificial intelligence to discover two new biological sub-types of multiple sclerosis ...
Dear Doctors: My older brother is 33 years old and was recently diagnosed with multiple sclerosis. I don't want to bother him with a lot of questions, but I would like to learn more about it. Can you ...
ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results